Search alternatives:
significant decrease » significantly increased (Expand Search)
significant new » significant non (Expand Search), significant genes (Expand Search), significant anti (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
significant decrease » significantly increased (Expand Search)
significant new » significant non (Expand Search), significant genes (Expand Search), significant anti (Expand Search)
new decrease » nn decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
-
2141
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
2142
-
2143
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
2144
-
2145
-
2146
-
2147
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
2148
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
2149
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
2150
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
2151
-
2152
-
2153
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
2154
-
2155
-
2156
-
2157
-
2158
-
2159
-
2160